A mixture ofthe aliphatic alcohol, triacontanol, aiid other chemically associated naturally occurritig alcohols was applied to the denuded dorsal cutaneous surface of guinea pigs to evaluate anti-inflammatory activity. In the setting of a chemical irritation with 2% croton oil and in an allergic dermatitis created with dinitrochlorobenzene sensitization and challenge, the triacontanol-containing preparation was signiftcantly more effective than vehicle alone (DHL skin cream) but not as effective as 0.05% Diprolene® ointment.
A mixture ofthe aliphatic alcohol, triacontanol, aiid other chemically associated naturally occurritig alcohols was applied to the denuded dorsal cutaneous surface of guinea pigs to evaluate anti-inflammatory activity. In the setting of a chemical irritation with 2% croton oil and in an allergic dermatitis created with dinitrochlorobenzene sensitization and challenge, the triacontanol-containing preparation was signiftcantly more effective than vehicle alone (DHL skin cream) but not as effective as 0.05% Diprolene® ointment.
Lymphocyte stimulation was studied by tritiated thymidine uptake and morphologic examination for blast transformation. When triacontanol-containing compounds were solubilized in aqueous media, effects on lymphocytes were insignificant. When solubilized in ethanol, there was a marked effect on thymidine uptake but not on blast transformation when compared to parallel controls. J Invest Dermatol 89: [380] [381] [382] [383] 1981 T he need exists for nonstcroid-bascd .Tnti-iiiflanimatory skill preparations. Potent halogcnatcd steroid conipotinds commonly used today cannot be applied safely to facial skin, and arc occasionally absorbed into areas where they are systemically active. Many naturally occurring preparations have been sotight for their reported medicinal values, only to be found ineffective in controlled studies. One such naturally occurring compound, triacontanol, is relatively ubiquitous in plant products and has been known to be effective as a plant growth regulator for many years [1, 2] . As these compounds are regularly ingested in our diets and deemed safe by regulatory agencies, limited studies bave been conducted in humans. Preliminary studies in humans indicated potential antiinflammatory and anti-Herpes Simplex properties when applied topically (personal observations, L. L. Clark, 1981 Clark, -1986 , and prompted tbis animal study to evaluate efficacy in controlled trials.
Chemically, triacontanol is a 30-carbon alcohol, present in significant concentrations in beeswax, and associated witb multiple contaminating fatty acid esters and other free acids [3] , It bas a solubility of <1()""' molar in aqueous media, is only sligbtly more soluble in ethanol, but has excellent lipid solubility |4,5]. Previous studies in plants bave utilized suspensions of triacontanol to circumvent tbis problem of relative water insolubility and bave been sticcesstul. Restilts of earlier animal sttidies (tinptiblished data) stiggest tbat tbese triacontanol-containing compotmds possess moderate anti-inflammatory activity. Tliis study was undertaken to evaluate tbe effectiveness of a mixture of tbese compounds in Manuscript received April 11, 1986 ; accepted for publication December 1, 1986 66.6% 30-carbon alcohol, and 16,6% .32-carbon length alcohol components. Mixture purity of >99.97o was verified by gas chro-: | niatography prior to use in this sttidy. The DHL veliicle and triacontanol-containing suspensions were prepared by Dr, Robert ; Petersen (University of Utah College of Pliarmacy, .Salt Lake City, Utah). Triacontanol was blended into suspension on a proi-'portional weight basis with vehicle. Constituents of the DHL , vehicle are listed by percentage of total compound weight: water 54.7%, isopropyl myristate 22.0%, glycerol nionostearate 6.0%. isopropyl lanolate 5.0%, triacontanol compound 5.0%, propylene glycol 5.0%, triethanolamine 1.3%, and Germaben-II® 1.(1% (Sutton Labs. hic). The blending process consisted ot a 2-component liquification at75°C, liquid phase mixing, then continuous nnxing while rettirning to a cream base preparation at room temperature. Diprolene* ointment 0.05% was obtained from Schermg Corporation, Kenilworth. New jersey. pH|Tliyinidine (6.7 Ci/mmol) was obtained from New England Nuclear, Boston, Massachusetts.
Treatment Regimen Eacli animal was subjected to 5 modes of treatment consisting of: (1) no treatment; (2) vehicle alone (DHL skin cream); (3) 1% triacontanol suspension in DHL vehicle; (4) 5% triacontanol suspension in DHL vehicle; and (5) Diprolene* ointment 0.05%, a very potent topical corticosteroid known to be effective in depressing skin inflammation. Approximately 250 mg of each compound was administered 3 times/day by manually rubbing the drtigs onto each of the respective test areas. The animals were isolated one to a cage. The guinea pigs were examined daily by a single-blinded e.xpert observer, and inflammation/irritation were recorded qualitatively utilizing a 1 + (no erythema) to 4+ (severe erythema/untreated control area) scoring system for each test area. Nair was again applied (for 4-min duration only) on day 4 of therapy to return the skin to a -fdenuded condition and expedite reading of erythema.
Allergic Sensitization Each of 12 experimental animals had the hair removed from their right Hank area via close clipping without anesthesia. Sensitization was accomplished using topical application of 10% DNFB in acetone (vol/vol) onto the clipped right flank area via dripping the solution onto the skin from a graduated 1.0 ml syringe (Pharmaseal Laboratories, Glendale, California) and isolating the animals for 20 min to allow solvent evaporation. At 4 days the animals were challenged with 0.02 ml of 5% DNCB in acetone (wt/vol) applied to the left ear to verify sensitization. A dose-response curve for DNCB in acetone (0.1%-5.()%) was performed on the left car of 5 sensitized animals to determine the concentration of DNCB yielding tlie optimal state of contact sensitization on visual inspection 24 h later. The animals were subsequently challenged with a 2' yo DNCB .solution delivered as 0.2 ml aliquots onto each ofthe 5 outlined test areas (total volume of 1.0 ml) from a 1.0 ml .syringe. Two hours after receiving the challenge dose, tlic animals were started on the treatment regimen outlined above.
Skin Inflammation From Chemical Irritation
Eacli of 12 experimental animals with denuded dorsal areas was treated with a l"/o solution of croton oil in acetone/ethanol (70%/30%). The croton oil was delivered to the skin via a 1.0 ml syringe, 0.2 ml to each test area, as described above. Treatment was initiated 2 li atter application ot the irritant solution, and each animal was examined daily as described above.
Human Lymphocyte Blast Transformation Human peripheral blood mononuclear lymphocytes (PBML) were obtained from healthy donors utilizing standard syringe venipuncture teclinique. A total of 35-40 nil of blood was obtained and heparinized using commercially available sodium heparin (Elkins-Sinn Inc.. Cherry Hill, New Jersey). Blood was mixed in a 1:1 ratio with RPMI 1640 tissue culture media (CIBCO Laboratories, Grand Island, New York), layered onto a "cushion" of Ficoll-Paquc® (Pharmacia Inc., Piscataway, New Jersey) and eentrifuged in a Beckman Model TJ-6R refrigerated centrifuge (Beckman Instruments, Palo Alto, California) for 45 min at 1200 rpm and 4°C [11] . The cell pellet was resuspended in 5.0 ml of RPMI 1640 media containing 10% fetal bovine serum and counted utilizing trypan blue exclusion techniques in a 0.1 ml Neubaner type heniacytometer (American Optieal. Buffalo, New York). Cells, 0.1 ml at 2 X lOVml were transferred to a Falcon Model 3072 96 well Bat bottom microtest plate (Becton Dickinson Labware, Oxnard, California). Solutions of pure triacontanol compound were obtained by: (1) serial dilutions of "saturated" stock solution (250 mg of triacontanol preparation stirred in 10 ml of RPMI tissue culture media tor 48 h) tollowed by vigorous centrifngation and filter sterilization; and (2) dissolving 100 mg of triacontanol preparation in 10 ml of absolute ethanol, filter sterilizing, and adding varying volumes to RPMI tissue culture media. Controls and varying concentrations ot triacontanol compounds were studied in the presence and absence ot PHA (phytohemaggltitinin) using standard methodologies. Blast tran.sformation was measured by quantitative lymphocyte counting and correlated with (^H]tliymidine uptake at 48 h.
RESULTS
All 24 animals were subjected to tlie same therapeutic modalities and were evaluated on a daily basis to determine efficacy of experimentally treated vs control areas. Treatments were performed with vehicle and test preparations simultaneously, and experimental treatment areas were varied among tlie animals between positions on the backs to minimize ettects ot regional variations on treatment results. All animals in both the croton oil irritation t T a b l e I. Significance of DHL Veliicle, 1% Triacontanol, 5% grotip and the DNCB sensitization group developed moderate to severe skin responses after apphcation of eitlier irritant preparation. Each experimental treatment regimen began 2 h after skin challenge with the respective sensitizing compound, and continued 3 times/day for 7 days. All treatment protocols (DHL vehicle, 1% and 5% triacontanol, and Diprolene* ointment) were statistically significant with respect to control with p < 0,07 for all 7 days tested (Table I) . In skin dose-response tolerance trials, DHL vehicle alone showed objective erythema in the absence of previous chemically induced irritation (unpublished data). Despite this fact, DHL vehicle was still significantly better than no treatment in all studies; therefore, all further studies compared experimental results with DHL vehicle' alone (Table II) , Averaged erythema scores for each treatment regimen on a daily basis are plotted in Figs 1 and 2 , Although not apparent from tlie data, the clinical severity of the skin inHanimation on each animal was tlie major determinant ot etticacy ill all treatment regimens.
Suiiiniary analysis shows that the 1% triacontaiiol-contaiiiing compound was statistically better {p < 0,10) than veliicle alone on 1 ot 7 test days for both DNCB and croton oil groups. The difference between vehicle and 5% triacontanol compound was significant (j) < 0,10) for 5 of 7 days in the croton oil arm and 3 of 7 days in tlie DNCB arm ot the study. In a few animals, the 5% triacontanol compound appeared to be almost as effective as the l^iprolene"" ointment in both tlie croton oil and DNCB groups. Diprolene™ ointineiit was clearly the most effective treatment regimen within the statistical limits of this small study (/) < 0.0022).
Due to the nature of the experimental protocol, as the control areas began to improve spontaneously the absolute differences between test and control areas became less. This made evaluations past 7 days difficult because all treatment area scores began to approach tlie score of the control area, which had arbitrarily been set at 4 + for each daily observation. Reference to untreated normal skin was difficult to quantitatively separate from Diprolene* treateci skin, and yielded no additional iiitormatioii.
Lymphocyte stimulation was studied by ['Hjthyniidine uptake and morphologic blast transformation. Purified triacontanol compound containing mixed 28-, 30-, and 32-carbon alcohols is only poorly soluble in water (<10~"'M), and often forms suspensions or crystallizes out of solution when placed in aqueous media. N o characterization of these solutions was attempted to define the state of the triacontanol in them, but when dissolved to niaxiniuni solubility in RPMI 1640 tissue culture media, there were no demonstrable effects on lymphocytes in tissue culture. Triacontanol compound dissolved in ethanol and then added to lymphocytes in tissue culture had a marked effect on thymidine uptake, bur very little effect on blast transformation. It is unclear whether this reflects lymphocyte activation or cellular damage, but ethanol controls had no similar effects when utilized alone (Table III) .
DISCUSSION
The present sttidies have compared the anti-inflamniatory etticacy of 2 triacontanol-containing compounds with 0.05% Diprolene* ointment using 2 inflammatory processes on the dorsal skin of guinea pigs as a model. The triacontanol compounds were clearly There is no way, from these data, to determine the relative potency of these triacontanol compounds as anti-inflammatory agents, but it would appear that they possess anti-inflammatory activity. The method of action is also unknown at this point, but higher concentrations of triacontanol compounds dissolved in ethanol seem to be lymphocyte inducers or cause moderate damage to the cells necessitating DNA repair activity. This lymphocyte activation may be more important in vivo since triacontanol is lipid soluble and could achieve higher concentrations in nonaqueous environments.
Triacontanol and the associated esters, alcohols, and free acids that often contaminate the natural preparations are very difficult to solubilize because ofthe waxy constituency ofthe compounds. This produced the major limiting factor in delivery of these chemicals to the skin. The 1% preparation was relatively easy to rub I into the skin, but the 5% preparation was not. Application ofthe 5 % preparation always resulted in a paste-like layer on the surface of the skin, and penetration of the entire aliquot was doubtful.
Improvement of the vehicle to allow easier application and less irritation may also increase the relative potency of these compounds. The need exists for potent anti-inflammatory agents without the side effects of corticosteroids. Results of the current studies suggest that triacontanol-containing mixtures may represent such an alternative class of drugs. Further studies will be necessary in order to define optimal formulations, doses, and application intervals for use of triacontanol-containing mixtures as nonsteroidal anti-inflammatory preparations.
